MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A/H5N1 viruses at low doses and after single immunization.
Human infections with highly pathogenic avian influenza viruses of the H5N1 subtype, frequently reported since 2003, result in high morbidity and mortality. It is feared that these viruses become pandemic, therefore the development of safe and effective vaccines is desirable. MVA-based H5N1 vaccines...
Main Authors: | Joost H C M Kreijtz, Yasemin Suezer, Gerrie de Mutsert, Geert van Amerongen, Astrid Schwantes, Judith M A van den Brand, Ron A M Fouchier, Johannes Löwer, Albert D M E Osterhaus, Gerd Sutter, Guus F Rimmelzwaan |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-11-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19915662/pdf/?tool=EBI |
Similar Items
-
Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus.
by: Rogier Bodewes, et al.
Published: (2009-01-01) -
Induction of Influenza (H5N8) Antibodies by Modified Vaccinia Virus Ankara H5N1 Vaccine
by: Rory D. de Vries, et al.
Published: (2015-06-01) -
Reassortment between Avian H5N1 and human influenza viruses is mainly restricted to the matrix and neuraminidase gene segments.
by: Eefje J A Schrauwen, et al.
Published: (2013-01-01) -
Highly Pathogenic Avian Influenza Virus (H5N1) Infection in Red Foxes Fed Infected Bird Carcasses
by: Leslie A. Reperant, et al.
Published: (2008-12-01) -
Emergence and spread of novel H5N8, H5N5 and H5N1 clade 2.3.4.4 highly pathogenic avian influenza in 2020
by: Nicola S. Lewis, et al.
Published: (2021-01-01)